论文部分内容阅读
目的:分析研究应用甘利欣治疗肝炎病毒性传染病的效果。方法:选取我院201 2年9月~2013年9月收治的肝炎病毒传染病患者1 90例,依照随机的方式将其分为两组,即对照组与实验组,每组例数均为95例。结果:与对照组相比,实验组的治疗效果明显比对照组好,其治疗有效率较高,且两组患者之间存在差异具有统计学意义,(P<0.05)。结论:应用甘利欣进行肝炎病毒传染病的治疗,能够对其病症表现起到较为明显的改善作用,减少患者体内存在的谷丙转氨酶及胆红素,且具有极强的安全可靠性。
Objective: To analyze the effect of Glycyrrhizin in the treatment of hepatitis virus infectious diseases. Methods: One hundred and ninety-nine patients with hepatitis B virus infection admitted to our hospital from September 2012 to September 2013 were randomly divided into two groups, control group and experimental group. The number of cases in each group was 95 cases. Results: Compared with the control group, the therapeutic effect of the experimental group was significantly better than that of the control group, and the treatment efficiency was high. The difference between the two groups was statistically significant (P <0.05). Conclusion: The application of Gan Lixin for the treatment of hepatitis virus infection can play a significant role in the improvement of its symptoms, reducing the presence of alanine aminotransferase and bilirubin in patients with high safety and reliability.